                         SEQUENCE LISTING

<110>  University of Copenhagen
 
<120>  Syntenin inhibitors and uses thereof

<130>  P4337PC00

<160>  67    

<170>  PatentIn version 3.5

<210>  1
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  fluorescent peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is TAMRA (a fluorophore)

<400>  1

Xaa Asn Asn Gly Ser His Trp Thr Ile Asp Ile 
1               5                   10      


<210>  2
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  fluorescent peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is TAMRA (a fluorophore)

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  X is L-cyclohexylglycine (CHG)

<400>  2

Xaa Asn Asn Gly Ser His Trp Xaa Xaa Asp Ile 
1               5                   10      


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  3

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  amidated peptide

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  X is an amino group (-NH2)

<400>  4

Ser His Trp Thr Ile Asp Ile Xaa 
1               5               


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<400>  5

His Trp Thr Ile Asp Ile 
1               5       


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<400>  6

Trp Thr Ile Asp Ile 
1               5   


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(4)
<223>  peptide

<400>  7

Thr Ile Asp Ile 
1               


<210>  8
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  8

Ala His Trp Thr Ile Asp Ile 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  9

Ser Ala Trp Thr Ile Asp Ile 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  10

Ser His Ala Thr Ile Asp Ile 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  11

Ser His Trp Ala Ile Asp Ile 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  12

Ser His Trp Thr Ala Asp Ile 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  13

Ser His Trp Thr Ile Ala Ile 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  14

Ser His Trp Thr Ile Asp Ala 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Serine

<400>  15

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-histidine

<400>  16

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-tryptophan

<400>  17

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-threonine

<400>  18

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  19
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-isoleucine

<400>  19

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  20
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-aspartic acid

<400>  20

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  21
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-isoleucine

<400>  21

Ser His Trp Thr Ile Asp Ile 
1               5           


<210>  22
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  22

Ser His Phe Thr Ile Asp Ile 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  23

Ser His Tyr Thr Ile Asp Ile 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is L-beta-(1-naphthyl)-alanine (1NAL)

<400>  24

Ser His Xaa Thr Ile Asp Ile 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is L-beta-(3-benzothienyl)-alanine (B-3)

<400>  25

Ser His Xaa Thr Ile Asp Ile 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  26

Ser His Trp Val Ile Asp Ile 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  27

Ser His Trp Ser Ile Asp Ile 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is L-t-leucine (TLE)

<400>  28

Ser His Trp Xaa Ile Asp Ile 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  29

Ser His Trp Ile Ile Asp Ile 
1               5           


<210>  30
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  30

Ser His Trp Tyr Ile Asp Ile 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  31

Ser His Trp Thr Thr Asp Ile 
1               5           


<210>  32
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  32

Ser His Trp Thr Val Asp Ile 
1               5           


<210>  33
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is L-t-leucine (TLE)

<400>  33

Ser His Trp Thr Xaa Asp Ile 
1               5           


<210>  34
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is L-cyclohexylglycine (CHG)

<400>  34

Ser His Trp Thr Xaa Asp Ile 
1               5           


<210>  35
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  35

Ser His Trp Thr Ile Glu Ile 
1               5           


<210>  36
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  36

Ser His Trp Thr Ile Asp Thr 
1               5           


<210>  37
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<400>  37

Ser His Trp Thr Ile Asp Val 
1               5           


<210>  38
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is L-t-leucine (TLE)

<400>  38

Ser His Trp Thr Ile Asp Xaa 
1               5           


<210>  39
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is L-cyclohexylglycine (CHG)

<400>  39

Ser His Trp Thr Ile Asp Xaa 
1               5           


<210>  40
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is L-cyclohexylglycine (CHG)

<400>  40

Ser His Trp Xaa Xaa Asp Ile 
1               5           


<210>  41
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is L-cyclohexylglycine (CHG)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is L-t-leucine (TLE)

<400>  41

Asp Xaa Xaa His Ile Trp Ser 
1               5           


<210>  42
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(6)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is L-cyclohexylglycine (CHG)

<400>  42

His Trp Xaa Xaa Asp Ile 
1               5       


<210>  43
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is L-cyclohexylglycine (CHG)

<400>  43

Trp Xaa Xaa Asp Ile 
1               5   


<210>  44
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  biotin-PEG2-peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X is biotin

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X is two polyethylene glycol (PEG) residues

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X is L-cyclohexylglycine (CHG)

<400>  44

Xaa Xaa Ser His Trp Xaa Xaa Asp Ile 
1               5                   


<210>  45
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  X is L-cyclohexylglycine (CHG)

<400>  45

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Ser His Trp Xaa Xaa 
1               5                   10                  15      


Asp Ile 
        


<210>  46
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is L-cyclohexylglycine (CHG)

<400>  46

Arg Arg Arg Gly Arg Lys Lys Arg Arg Ser His Trp Xaa Xaa Asp Ile 
1               5                   10                  15      


<210>  47
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  X is L-cyclohexylglycine (CHG)

<400>  47

Lys Arg Arg Arg Gly Arg Lys Lys Arg Arg Glu Ser His Trp Xaa Xaa 
1               5                   10                  15      


Asp Ile 
        


<210>  48
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  X is L-cyclohexylglycine (CHG)

<400>  48

Lys Arg Arg Arg Gly Arg Lys Lys Arg Arg Glu Ser His Trp Xaa Xaa 
1               5                   10                  15      


Asp Ile 
        


<210>  49
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  X is L-cyclohexylglycine (CHG)

<400>  49

Arg Arg Arg Arg Arg Arg Arg Arg Arg Ser His Trp Xaa Xaa Asp Ile 
1               5                   10                  15      


<210>  50
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  X is L-cyclohexylglycine (CHG)

<400>  50

Lys Arg Arg Arg Arg Arg Arg Arg Arg Arg Glu Ser His Trp Xaa Xaa 
1               5                   10                  15      


Asp Ile 
        


<210>  51
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(18)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  X is L-cyclohexylglycine (CHG)

<400>  51

Lys Arg Arg Arg Arg Arg Arg Arg Arg Arg Glu Ser His Trp Xaa Xaa 
1               5                   10                  15      


Asp Ile 
        


<210>  52
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic seqquence


<220>
<221>  MISC_FEATURE
<222>  (1)..(5)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X3 is selected from the group consisting of W and 
       beta-(3-benzothienyl)-alanine (B-3)

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X4 is selected from the group consisting of T, A, V, S, I, Y and 
       L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X5 is selected from the group consisting of I, L-t-leucine (TLE) 
       and L-cyclohexylglycine (CHG)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X6 is selected from the group consisting of D and E

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X7 is selected from the group consisting of I, V, L-t-leucine 
       (TLE) and L-cyclohexylglycine (CHG)

<400>  52

Xaa Xaa Xaa Xaa Xaa 
1               5   


<210>  53
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X1 is selected from the group consisting of S, A and D-serine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  X2 is selected from the group consisting of H, A and D-histidine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X3 is selected from the group consisting of W and 
       beta-(3-benzothienyl)-alanine (B-3)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X4 is selected from the group consisting of T, A, V, S, I, Y and 
       L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X5 is selected from the group consisting of I, L-t-leucine (TLE) 
       and L-cyclohexylglycine (CHG)

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X6 is selected from the group consisting of D and E

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  X7 is selected from the group consisting of I, V, L-t-leucine 
       (TLE) and L-cyclohexylglycine (CHG)

<400>  53

Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5           


<210>  54
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<400>  54

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  55
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(16)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-tryptophan

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-methionine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-asparagine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  D-glutamine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-tryptophan

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  D-isoleucine

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  D-isoleucine

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  D-glutamine

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  D-arginine

<400>  55

Lys Lys Trp Lys Met Arg Arg Asn Gln Phe Trp Ile Lys Ile Gln Arg 
1               5                   10                  15      


<210>  56
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  peptide

<400>  56

Lys Leu Ala Leu Lys Leu Ala Leu Lys Leu Ala Lys Ala Ala Leu Lys 
1               5                   10                  15      


Ala 
    


<210>  57
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<400>  57

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  58
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(19)
<223>  peptide

<400>  58

Arg Gly Gly Arg Leu Ser Tyr Ser Arg Arg Arg Phe Ser Thr Ser Thr 
1               5                   10                  15      


Gly Arg Ala 
            


<210>  59
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  59

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  60
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-glutamine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-glycine

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  D-tyrosine

<400>  60

Arg Arg Arg Gln Arg Arg Lys Lys Arg Gly Tyr 
1               5                   10      


<210>  61
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  D-arginine

<400>  61

Arg Arg Arg Gly Arg Lys Lys Arg Arg 
1               5                   


<210>  62
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  cyclic peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-arginine

<400>  62

Lys Arg Arg Arg Gly Arg Lys Lys Arg Arg Glu 
1               5                   10      


<210>  63
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  D-arginine

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-lysine

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  D-arginine

<400>  63

Lys Arg Arg Arg Gly Arg Lys Lys Arg Arg Glu 
1               5                   10      


<210>  64
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  peptide

<400>  64

Lys Arg Arg Arg Arg Arg Arg Arg Arg Arg Glu 
1               5                   10      


<210>  65
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  cyclic peptide

<400>  65

Lys Arg Arg Arg Arg Arg Arg Arg Arg Arg Glu 
1               5                   10      


<210>  66
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  X is L-t-leucine (TLE)

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  X is L-cyclohexylglycine (CHG)

<400>  66

Cys Ser His Trp Xaa Xaa Asp Ile 
1               5               


<210>  67
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  peptide

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  X is L-cyclohexylglycine (CHG)

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  X is L-t-leucine (TLE)

<400>  67

Cys Asp Xaa Xaa His Ile Trp Ser 
1               5               


